An Evaluation of the Commercially Available Medtronic Resolute Integrity Zotarolimus-Eluting Coronary Stent System
Completed · Not applicable
Conditions studied: Coronary Artery Disease
In brief
The purpose of this post approval study is to conduct a prospective, multicenter evaluation of the procedural and clinical outcomes of subjects that are treated with the commercially available Medtronic Resolute Integrity Zotarolimus-Eluting Coronary Stent System.
Key facts
- Study ID
- NCT01638507
- Run by
- Medtronic Vascular
- People needed
- 230
- Starts
- 2012-07-01
- Expected to finish
- 2015-06-01
- Last updated by the study team
- 2019-04-03
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- St. Joseph's Hospital Health Center — Syracuse, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.